ARCHIVES

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Plans For Research In Breast, Prostate Cancer, Drafted

January 28, 1994

FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations

August 14, 1992

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007